» Articles » PMID: 21876630

Nutrition and Physical Activity in NAFLD: an Overview of the Epidemiological Evidence

Overview
Specialty Gastroenterology
Date 2011 Aug 31
PMID 21876630
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

Nonalcoholic fatty liver disease (NAFLD) has been recognized as a major health burden. The high prevalence of NAFLD is probably due to the contemporary epidemics of obesity, unhealthy dietary pattern, and sedentary lifestyle. The efficacy and safety profile of pharmacotherapy in the treatment of NAFLD remains uncertain and obesity is strongly associated with hepatic steatosis; therefore, the first line of treatment is lifestyle modification. The usual management of NAFLD includes gradual weight reduction and increased physical activity (PA) leading to an improvement in serum liver enzymes, reduced hepatic fatty infiltration, and, in some cases, a reduced degree of hepatic inflammation and fibrosis. Nutrition has been demonstrated to be associated with NAFLD and Non-alcoholic steatohepatitis (NASH) in both animals and humans, and thus serves as a major route of prevention and treatment. However, most human studies are observational and retrospective, allowing limited inference about causal associations. Large prospective studies and clinical trials are now needed to establish a causal relationship. Based on available data, patients should optimally achieve a 5%-10% weight reduction. Setting realistic goals is essential for long-term successful lifestyle modification and more effort must be devoted to informing NAFLD patients of the health benefits of even a modest weight reduction. Furthermore, all NAFLD patients, whether obese or of normal weight, should be informed that a healthy diet has benefits beyond weight reduction. They should be advised to reduce saturated/trans fat and increase polyunsaturated fat, with special emphasize on omega-3 fatty acids. They should reduce added sugar to its minimum, try to avoid soft drinks containing sugar, including fruit juices that contain a lot of fructose, and increase their fiber intake. For the heavy meat eaters, especially those of red and processed meats, less meat and increased fish intake should be recommended. Minimizing fast food intake will also help maintain a healthy diet. PA should be integrated into behavioral therapy in NAFLD, as even small gains in PA and fitness may have significant health benefits. Potentially therapeutic dietary supplements are vitamin E and vitamin D, but both warrant further research. Unbalanced nutrition is not only strongly associated with NAFLD, but is also a risk factor that a large portion of the population is exposed to. Therefore, it is important to identify dietary patterns that will serve as modifiable risk factors for the prevention of NAFLD and its complications.

Citing Articles

Assessment of ChatGPT-generated medical Arabic responses for patients with metabolic dysfunction-associated steatotic liver disease.

Alqahtani S, AlAhmed R, Alomaim W, Alghamdi S, Al-Hamoudi W, Bzeizi K PLoS One. 2025; 20(2):e0317929.

PMID: 39899495 PMC: 11790096. DOI: 10.1371/journal.pone.0317929.


The effect of healthy eating index-2015 in the associations of biological aging and non-alcoholic fatty liver disease: an interaction and mediation analysis.

Zhang X, Ding Z, Yan Y, Yang W, Ai X, Zhou Y J Health Popul Nutr. 2025; 44(1):18.

PMID: 39856713 PMC: 11761225. DOI: 10.1186/s41043-025-00755-z.


Relationship between macronutrients and energy intake and liver serum transaminase levels in elderly athletes and non-athletes: findings from the Neyshabur longitudinal study on aging.

Bilondi H, Arabi S, Mohammadzadeh F, Mirhafez S, Ostadrahimi A BMC Geriatr. 2024; 24(1):984.

PMID: 39616378 PMC: 11607926. DOI: 10.1186/s12877-024-05445-9.


Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies.

Bakhshimoghaddam F, Baez D, Dolatkhah N, Sheikh M, Poustchi H, Hekmatdoost A BMC Nutr. 2024; 10(1):153.

PMID: 39609906 PMC: 11606097. DOI: 10.1186/s40795-024-00961-8.


NORE1A loss promotes MASLD/MASH.

Donninger H, Hobbing K, Arteel G, Clark G Transgenic Res. 2024; 33(5):527-533.

PMID: 39251552 DOI: 10.1007/s11248-024-00407-8.


References
1.
Boule N, Haddad E, Kenny G, Wells G, Sigal R . Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001; 286(10):1218-27. DOI: 10.1001/jama.286.10.1218. View

2.
Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G . A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010; 53(2):372-84. DOI: 10.1016/j.jhep.2010.04.008. View

3.
Kendrick J, Targher G, Smits G, Chonchol M . 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2008; 205(1):255-60. DOI: 10.1016/j.atherosclerosis.2008.10.033. View

4.
Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G . Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2006; 17(7):517-24. DOI: 10.1016/j.numecd.2006.04.002. View

5.
Oza N, Eguchi Y, Mizuta T, Ishibashi E, Kitajima Y, Horie H . A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff. J Gastroenterol. 2009; 44(12):1203-8. DOI: 10.1007/s00535-009-0115-x. View